Viral RNA Extraction Kit Market

Viral RNA Extraction Kit Market Snapshot (2023 to 2033)

According to Future Market Insights research, during the projected period, the global market is expected to grow at a CAGR of 7.2%. The market value is projected to increase from USD 210.8 million in 2023 to USD 421.4 million by 2033. The global market was valued at USD 200.6 million at the end of 2022 and is anticipated to exhibit Y-o-Y growth of 6.3% in 2023.

Market Outlook:

Data Points	Market Insights
Market Value 2022	USD 200.6 Million
Market Value 2023	USD 210.8 Million
Market Value 2033	USD 421.4 Million
CAGR 2023 to 2033	7.2%
Share of Top 5 Countries	58.4%
Key Players	The key players in the Global Market Are Bio Rad Laboratories Inc.; ThermoFisher Scientific; Promega Corporation; Agilent Technologies; Bioneer Corporation; PerkinElmer Inc.; LGC Biosearch Technologies; Qiagen; General Biosystems; Takara Bio Inc.; Roche Life Science; GeneReach Biotechnology Corporation; Merck Millipore; BioFire Defense LLC; Akonni Biosystems; Inc. and Primerdesign Ltd.

The process of RNA extraction, also known as RNA isolation, involves the separation of RNA from a cell. The utilization of this technique is advantageous in various applications such as gene expression analysis, pathogen identification, and classification. Due to its reliance on nucleic acid detection, this technique exhibits high levels of accuracy, reproducibility, and versatility.

The RNA of a living cell, regardless of its origin from an animal, plant, human, bacteria, or virus, is a valuable source of information regarding genetic material. As such, it is a crucial component of gene expression studies. The RNA lysis buffer is known to facilitate the lysis of the cell wall/membrane, whereas the utilization of organic solvents, such as phenol-chloroform, is commonly employed to effectuate the separation of RNA via centrifugation. The utilization of Phenol: Chloroform: Isoamyl alcohol in conjunction with centrifugation results in the formation of three distinct layers. These layers consist of the lower organic layer, the middle layer containing DNA and protein, and the upper aqueous layer containing RNA. The upper aqueous phase is carefully collected and subsequently subjected to precipitation, washing, and dissolution in RNase-free water.

RNA extraction plays an important role in cancer genetic research. It involves mutation analysis, comparative genomic hybridization, and microsatellite analysis. The rising incidence of cancer globally is resulting in the need for advanced RNA extraction kits, which in turn is expected to drive the market in the upcoming years.

Overall, the increasing adoption of the latest technologies such as mutation analysis and comparative genomic hybridization, the prevalence of cancer and the need for advanced genomic techniques, this factors will boost the market in the future.

Sales Analysis of Global Market from 2017 to 2022 Vs Market Outlook for 2023 to 2033

Sales of the global market grew at a CAGR of 8.6% between 2017 and 2022. The global market contributes 16.5% revenue share to the global extraction kit market valued at USD 1.2 billion in 2022.

The accurate detection and monitoring of viral RNA are essential for understanding the prevalence, transmission, and control of viral diseases. Thus, RNA extraction kits play a critical role in diagnosing viral infections and conducting epidemiological surveillance.

Technological advancements, such as real-time polymerase chain reaction (PCR), real-time reverse transcription–polymerase chain (RT-PCR), and next-generation sequencing, have revolutionized molecular diagnostics. The increasing adoption of molecular diagnostic methods drives the demand for the global market.

During outbreaks and pandemics, the rapid and accurate detection of viral RNA is crucial for effective public health response. Extraction kits enable healthcare professionals and researchers to quickly identify the presence of viral pathogens, assess the extent of the outbreak, and implement appropriate control measures.

Viral RNA extraction kits are indispensable tools for researchers studying viral diseases. These kits enable the isolation and analysis of viral RNA, providing insights into viral pathogenesis, genetic diversity, and potential therapeutic targets. Advancements in research contribute to the development of new and improved extraction kits.

Considering this, FMI expects the global market to grow at a CAGR of 7.2% through 2023 to 2033.

What are the Key Opportunities for Key Players in the Viral RNA Extraction Kit Market?

In recent years, government agencies in the Asia-Pacific and the Middle East have easily encouraged manufacturers to drive industrial growth in the healthcare and bio-pharmacy industries. Key players can take advantage of regulatory scenarios to grow in the market.

For example, developing countries in the Asia-Pacific region, such as India, have lifted export restrictions on diagnostic kits and reagents, including equipment such as extraction kits and systems used to detect coronavirus infections.

In the COVID-19 pandemic, the life sciences division played a crucial role. Traditional competitors banded together to speed up research and develop the fastest new vaccines to combat the worldwide issue. The science, technology, and innovation (STI) response to COVID-19 is based on collaboration, with national and international collaborative platforms for technology, revolutionizing vaccine design and production.

Favourable government policies and rising research initiatives, collaboration activities amongst countries like the U.S. is supposed to set out promising open doors for key market players.

These factors are expected to provide growth opportunities to key players in the market over the forecast period.

Which Factors Could Possibly Restrain the Growth of the Global Market?

The promotion of a mainstream biotech industry by several governments, akin to the extraction kit model, has encountered sluggish progress. It has been observed that the growth and progress of various regions are contingent upon the availability of proficient experts. A significant disparity has been observed by numerous organizations between proficient experts and the present labour pool. The dearth of seasoned professionals has impeded market expansion in numerous developing nations.

Changing regulatory dynamics is one of the restraining factors for the market such as each country's regulatory authorities and procedures may differ. While many follow the standards of large countries, such as the United States Food and Drug Administration (FDA), others have their approval timelines. In such circumstances, one provider is unable to introduce new or better items until all extraction kits have been validated.

Before beginning the distribution of their product or equipment, companies must wait for all regulatory approvals to be received. Validation is not necessary for US FDA-approved kits, however, it is essential for CE-IVD authorized/non-US FDA approved/indigenous kits, which require batch testing.

These factors are expected to hamper the revenue growth of the extraction kit market over the forecast period.

Country-wise Insights

What Makes the U.S. the Dominating Country in the Global Market?

In the United States, the adoption of extraction kits is more due to extensive research and development activities in the fields of molecular biology.

The United States has a robust biotechnology and pharmaceutical industry that heavily relies on RNA extraction kits. Companies involved in drug discovery, diagnostic development, and therapeutic research require high-quality RNA samples for their research and development pipelines.

• Example: Moderna, an American biotechnology company, played a crucial role in the development of mRNA-based COVID-19 vaccines. They utilized RNA extraction kits to extract and purify messenger RNA (mRNA) from the virus for vaccine development.

During the projected period, the U.S. market accounted for around 31.9% of the global market share in 2022.

Due to the advanced pharmaceutical and biotechnological industry in the U.S., there will be increasing demand for RNA extraction kits, which will drive the expansion of the market.

Why is Germany considered to be a Lucrative Segment in the Global Market?

Germany dominated the European market and accounted for 7.5% of the global market share in the year 2022.

Germany has a strong research and development landscape, with renowned research institutions and universities engaged in virology research. Researchers studying viral diseases rely on extraction kits to isolate and analyze viral RNA for understanding the pathogenesis, developing vaccines, and designing therapeutic strategies.

• Example: The Robert Koch Institute (RKI), Germany's national public health institute, conducts research on infectious diseases, including viral infections. Researchers at RKI use extraction kits in their studies to investigate the transmission dynamics, genetic variability, and epidemiology of viruses.

Due to the strong research and development and German government support and funding, there will be demand for RNA extraction kits, which will drive the expansion of the market.

What Makes China an Emerging Market in the Global Presence?

China dominated the East Asia market and accounted for around 49.6% of the regional market share in the year 2022.

China has the world's largest population, which increases the demand for the global market for diagnosing and monitoring viral infections. The country's focus on public health and disease control requires reliable tools for viral RNA detection and surveillance.

• Example: In October 2020, During the COVID-19 pandemic, China's National Health Commission recommended the use of viral RNA extraction kits for detecting SARS-CoV-2, the virus causing COVID-19. This led to a surge in demand for global market across the country

Global market demand is rising as more individuals become aware of the test and are thus more likely to adapt to the testing procedure.

Category-wise Insights

Why are Nasal washes and Swab Largely Adopted in the Global Market?

The nasal washes and swab segment held significant chunk of about 37.9% in global market by the end of 2022.

Nasal washes and swabs allow for direct sampling of the respiratory tract, where many respiratory viruses, including SARS-CoV-2 (the virus causing COVID-19), primarily infect. These sample types can capture the virus directly from the nasal cavity, nasopharynx, or oropharynx, providing a representative sample of the viral load present in the respiratory system.

Non-invasive collection and high viral load in respiratory secretions are one of the reasons for the increasing adoption of nasal swabs.

Overall, nasal washes and the swab is used as sample type for RNA extraction due to their high specificity.

Which Application Segment Dominates the Global Market in 2022?

The disease diagnosis segment accounted for a revenue share of 37.1% in the global market at the end of 2022.

The utilization of viral RNA extraction kits is crucial in the identification of viral infections. It has been observed that various viruses, including but not limited to SARS-CoV-2 (COVID-19), influenza viruses, and respiratory syncytial virus (RSV), possess RNA as their genetic material.

By isolating and extracting viral RNA from patient samples, it becomes possible to detect the presence of the virus and diagnose the corresponding viral infection.

Overall, disease diagnosis offers monitoring of treatment efficiency, making it the most significant sample for this segment.

Which End User in the Global Market Dominated in the Year 2022?

The diagnostic laboratories segment accounted for a revenue share of 30.1% in the global market at the end of 2022.

Diagnostic laboratories are essential for the global market as they ensure accurate diagnosis, maintain quality standards, validate tests, handle high testing volumes, provide expert interpretation, and contribute to collaborative networks for effective disease management.

Overall, diagnostic Laboratories offer convenient testing options, making them the dominant end user for this segment.

Competitive Landscape

The viral RNA extraction kit market's major companies are concentrating on diversifying their product offerings to boost their market share and establish a presence in developing nations. Pricing strategies, market strategies, technology improvements, regulatory compliance, and acquisition and distribution agreements with other firms to extend their company are the main tactics used by manufacturers to acquire a competitive advantage in the market.

For instance:

• In September 2022, HiMedia launched Monkeypox RT-PCR and viral RNA extraction kits for the detection of Monkeypox.

Similarly, recent developments have been tracked by the team at Future Market Insights related to companies in the global market space, which are available in the full report

Scope of the Global Viral RNA Extraction Kit Market Report

Attribute	Details
Forecast Period	2023 to 2033
Historical Data Available for	2017 to 2022
Market Analysis	USD Million for Value, Units for Volume
Key Regions Covered	North America; Latin America; Europe; South Asia; East Asia; Oceania; Middle East and Africa (MEA)
Key Countries Covered	USA, Canada, Brazil, Mexico, Argentina, Germany, U.K., France, Italy, Spain, Russia, BENELUX, Nordics, China, Japan, South Korea, India, Thailand, Indonesia, Malaysia, Australia, New Zealand, Türkiye, South Africa, North Africa and GCC Countries
Key Segments Covered	Sample Type, Application, End User, Region
Key Companies Profiled	Bio Rad Laboratories Inc.; ThermoFisher Scientific; Promega Corporation; Agilent Technologies; Bioneer Corporation; PerkinElmer Inc.; LGC Biosearch Technologies; Qiagen; General Biosystems; Takara Bio Inc.; Roche Life Science; GeneReach Biotechnology Corporation; Merck Millipore; BioFire Defense LLC; Akonni Biosystems, Inc.; Primerdesign Ltd.
Report Coverage	Market Forecast, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, Strategic Growth Initiatives
Customization & Pricing	Available upon Request

Key Segments Covered in Global Viral RNA Extraction Kit Market Industry Research

By Sample Type:

• Nasal Washes and Swab
• Sputum
• Saliva
• Fecal & Stool
• Urine
• Blood
• Tissues
• Others

By Applications:

• Disease Diagnosis
• Drug Discovery
• Cancer Research
• cDNA Library
• Others

By End User:

• Hospitals
• Academic & Research Institutes
• Pharmaceutical & Biotechnology Companies
• Clinical Research Organizations
• Diagnostic Laboratories
• Forensic Labs

By Region:

• North America
• Latin America
• Europe
• South Asia
• East Asia
• Oceania
• Middle East & Africa (MEA)

Frequently Asked Questions

What is the Projected CAGR of the Viral RNA Extraction Kit Market by 2033?

The projected CAGR of the viral RNA extraction kit market by 2033 is 7.2%.

What is the Projected Viral RNA Extraction Kit Market value by 2033?

The projected market value by 2033 is USD 421.4 million.

What is the Current Viral RNA Extraction Kit Market Valuation?

The market is estimated to secure a valuation of USD 210.8 million in 2023.

Which Industry is the Key Consumer of the Viral RNA Extraction Kit Market?

The health and diagnostic industry is the leading consumer of the market.

What are the Opportunities in the Viral RNA Extraction Kit Market?

The increasing prevalence of viral infections is the key opportunity in the kit market.